Filing Details

Accession Number:
0001628280-20-014283
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-05 16:16:14
Reporting Period:
2020-10-05
Accepted Time:
2020-10-05 16:16:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1127537 Pulmonx Corp LUNG Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222358 Jr. G Dana Mead C/O Kleiner Perkins Caufield &Amp; Byers
2750 Sand Hill Road
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-05 1,268,411 $0.00 1,268,411 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-10-05 168,223 $0.00 1,436,634 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-10-05 87,475 $0.00 1,524,109 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-10-05 26,315 $19.00 26,315 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C-1 Preferred Stock Disposition 2020-10-05 1,268,411 $0.00 1,268,411 $0.00
Common Stock Series D-1 Preferred Stock Disposition 2020-10-05 168,223 $0.00 168,223 $0.00
Common Stock Series E-1 Preferred Stock Disposition 2020-10-05 87,475 $0.00 87,475 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
  2. The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.